Abstract:The control of retroviral infection by antiviral factors referred to as restriction factors has become an exciting area in infectious disease research. TRIM5α has emerged as an important restriction factor impacting on retroviral replication including HIV-1 replication in primates. TRIM5α has a tripartite motif comprising RING, B-Box and coiled coil domains. The antiviral α splice variant additionally encodes a B30.2 domain which is recruited to incoming viral cores and determines antiviral specificity. TRIM5 is ubiquitinylated and rapidly turned over by the proteasome in a RING dependent way. Protecting restricted virus from degradation, by inhibiting the proteasome, rescues DNA synthesis, but not infectivity, indicating that restriction of infectivity by TRIM5α does not depend on the proteasome but the early block to DNA synthesis is likely to be mediated by rapid degradation of the restricted cores. The peptidyl prolyl isomerase enzyme cyclophilin A isomerises a peptide bond on the surface of the HIV-1 capsid and impacts on sensitivity to restriction by TRIM5α from Old World monkeys. This suggests that TRIM5α from Old World monkeys might have a preference for a particular capsid isomer and suggests a role for cyclophilin A in innate immunity in general. Whether there are more human antiviral TRIMs remains uncertain although the evidence for TRIM19's (PML) antiviral properties continues to grow. A TRIM5-like molecule with broad antiviral activity in cattle suggests that TRIM mediated innate immunity might be common in mammals. Certainly the continued study of restriction of viral infectivity by antiviral host factors will remain of interest to a broad audience and impact on a variety of areas including development of animal models for infection, development of viral vectors for gene therapy and the search for novel antiviral drug targets.

Characterization of a Core Fragment of the Rhesus Monkey TRIM5α Protein

Characterization of TRIM5α Trimerization and Its Contribution to Human Immunodeficiency Virus Capsid Binding

Hexagonal assembly of a restricting TRIM5α protein

An all-atom view into the disordered interaction interface of the TRIM5α PRYSPRY domain and the HIV capsid

TRIM5α: A Protean Architect of Viral Recognition and Innate Immunity

Structural basis for PRYSPRY-mediated tripartite motif (TRIM) protein function

Retroviral Restriction Factors Trim5 Alpha: Therapeutic Strategy To Inhibit Hiv-1 Replication

The tripartite motif coiled-coil is an elongated antiparallel hairpin dimer

The Conserved Lys-95 Charged Residue Cluster is Critical for the Homodimerization and Enzyme Activity of Human Ribonucleotide Reductase Small Subunit M2*

Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5α-mediated restriction

Identification of a second binding site on the TRIM25 B30.2 domain.

Functional Analysis on the Anti-Hiv Activity of TRIM5α

The control of viral infection by tripartite motif proteins and cyclophilin A

TRIM5α polymorphism identification in cynomolgus macaques of Vietnamese origin and Chinese rhesus macaques

TRIM5α Modulates Immunodeficiency Virus Control in Rhesus Monkeys

Characterisation of class VI TRIM RING domains: linking RING activity to C-terminal domain identity

Structure and catalytic activation of the TRIM23 RING E3 ubiquitin ligase

TRIM5 is an innate immune sensor for the retrovirus capsid lattice

Molecular Mechanism Governing RNA-binding Property of Mammalian TRIM71 Protein.

Characterization and Biological Function Analysis of the Trim3a Gene from Zebrafish (danio Rerio)

Correlated cryogenic fluorescence microscopy and electron cryo-tomography shows that exogenous TRIM5α can form hexagonal lattices or autophagy aggregates in vivo